https://www.ndtvprofit.com/business/dr-reddy-s-gets-8-observations-from-usfda-for-its-duvvada-facility?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The FDA Form 483 notifies the company’s management of objectionable conditions.